Insider Trading & Ownership - Averill Madison Master Fund Ltd.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Averill Madison Master Fund Ltd.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-03-31
Purchase
2025-04-02
4:37 pm
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
Cowen Aaron
Director
10% Owner
16,497 $12.83 $211,736 1,068,701
(Indirect)
View
2025-03-26
Purchase
2025-03-28
4:51 pm
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
Cowen Aaron
Director
10% Owner
900,000 $13 $11,700,000 1,066,764
(Indirect)
View
2024-12-23
Purchase
2024-12-26
4:28 pm
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
Cowen Aaron
Director
10% Owner
47,520 $11.09 $527,174 960,554
(Indirect)
View
2024-12-03
Purchase
2024-12-05
4:36 pm
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
Cowen Aaron
Director
10% Owner
42,000 $9.6 $403,200 955,124
(Indirect)
View
2024-11-19
Purchase
2024-11-21
4:24 pm
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
Cowen Aaron
Director
10% Owner
41,436 $10.05 $416,616 950,314
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-26
Exercise
2024-09-30
5:17 pm
N/A
N/A
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
Cowen Aaron
Director
10% Owner
5,181,347 $3.86 4,758,835
(Indirect)
View
2024-09-26
Exercise
2024-09-30
5:17 pm
2022-12-09
2027-12-09
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
Cowen Aaron
Director
10% Owner
16,549,527 $0 4,758,835
(Indirect)
View
2024-09-26
Exercise
2024-09-30
5:17 pm
N/A
N/A
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
Cowen Aaron
Director
10% Owner
1,368,180 $0.0001 4,758,835
(Indirect)
View
2024-09-26
Exercise
2024-09-30
5:17 pm
N/A
N/A
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
Cowen Aaron
Director
10% Owner
588,236 $1.9299 4,758,835
(Indirect)
View

Ownership
2024-05-02
5:27 pm
N/A
N/A
Benitec Biopharma Inc. BNTC SUVRETTA CAPITAL MANAGEMENT LLC
Cowen Aaron
Averill Madison Master Fund Ltd.
Averill Master Fund Ltd.
10% Owner
0 $0 15,233,011
(Indirect)
View